That's interesting. If I combine their holdings, their stake in GXY has increased from about 21% at beginning of the year to almost 33% now. Big commitment (or maybe big bet) here.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
